A Robust DIA-Based Platform for Large-Scale Plasma Glycoproteomics and Biomarker Discovery
Structural changes in protein glycosylation are recognized as phenotypes in numerous diseases, including cancer. Despite the promise of glycoproteomics for diagnostic biomarker discovery, large-scale studies remain limited by challenges in reproducibility, throughput, and quantitative precision. Here, we present a ro...